Yuankai Shi

Chinese Academy of Medical Sciences - Peking Union Medical College

M.D.

Beijing 100021

China

Chinese Academy of Sciences (CAS) - Beijing Key Laboratory of Molecular Imaging

China

National Cancer Center Hospital

Research Center for Cancer Prevention and Screenin

Tokyo

Japan

Chinese Academy of Medical Sciences

NO. 9, Dongdan Santiao

Beijing, Dongcheng District

China

SCHOLARLY PAPERS

2

DOWNLOADS

38

CITATIONS

1

Scholarly Papers (2)

1.

Nivolumab versus Docetaxel in a Predominantly Chinese Patient Population with Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 078 Randomised Phase 3 Clinical Trial

Number of pages: 31 Posted: 25 Sep 2018
Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangdong Lung Cancer Institute, Department of Pulmonary Oncology, Shanghai Jiao Tong University (SJTU), Jilin Cancer Hospital, Tongji University, Chinese Academy of Sciences (CAS), The Chinese University of Hong Kong (CUHK), Sun Yat-Sen University (SYSU), Guangdong Academy of Medical Sciences, Hunan Cancer Hospital, Jiangsu Cancer Hospital - Department of Medical Oncology, Zhejiang Cancer Hospital, Leningrad Regional Clinical Hospital, Zhejiang University, Henan Cancer Hospital, Sichuan University - West China Hospital, Central South University, Chinese Academy of Medical Sciences - Peking Union Medical College, Bristol-Myers Squibb, Bristol-Myers Squibb and Fudan University
Downloads 27 (475,904)
Citation 1

Abstract:

Loading...

nivolumab; PD-1 inhibitor; non-small-cell lung cancer; NSCLC; China; docetaxel; immunotherapy

2.

Efficacy and Safety of Sintilimab for Relapsed/Refractory Classic Hodgkin Lymphoma: A Multicentre, Single-Arm Phase II Study (ORIENT-1)

Number of pages: 118 Posted: 24 Sep 2018
Chinese Academy of Medical Sciences - Peking Union Medical College, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Peking Union Medical College, Chinese Academy of Medical Sciences, Institute of Hematology and Blood Diseases Hospital, State Key Laboratory of Experimental Hematology
Downloads 11 (567,749)

Abstract:

Loading...

PD-1, classic Hodgkin's Lymphoma, relapsed/refractory, ORIENT-1